In a groundbreaking initiative for the Chinese health product market, Macao Innovatus Biotechnology Co., Ltd. has partnered with Hangzhou Hunter Biotech (https://www.zhunter.com) to utilize zebrafish assays as a scientific foundation for validating health product efficacy. This collaboration represents the first industry-standard application of zebrafish-based efficacy testing in China.
2025 Zebrafish Testing Industry Standard
In 2025, a formal zebrafish assay standard was introduced, establishing a unified methodology for evaluating health product effectiveness. This standard ensures reliable, consistent, and reproducible results, providing a scientifically credible basis for efficacy claims.
Certification and Product Marking Process
Aligned with this standard, a structured certification process has been implemented. Products validated through zebrafish assays can now receive an official certification mark, signaling compliance with the 2025 standard. This process enhances consumer trust and establishes a transparent operational framework for product validation and marketing.
A Pioneering Approach in China
This collaboration is the first of its kind in China, setting a new benchmark for scientifically validated health products. By combining Macao Innovatus Biotechnology’s market expertise with Hangzhou Hunter Biotech’s advanced zebrafish testing capabilities, the partnership leads the way for science-driven efficacy assessment, providing authoritative backing for health products in the Chinese market.